ERAS vs PODD · $4.13B cap vs P/E 34, rev $2.07B
Erasca Inc (ERAS) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Erasca Inc (ERAS) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
ERAS does not have a complete income-statement cache yet.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
ERAS currently screens at market cap $4.13B. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the ERAS and PODD stock pages for the full models.
Not investment advice.